UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study

The Lancet infectious diseases, 2012, Vol.12 (1), p.19-26

2012

Link zum Volltext

Verfügbarkeit prüfen

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment

PLoS pathogens, 2020-08, Vol.16 (8), p.e1008791-e1008791

2020

Link zum Volltext

Verfügbarkeit prüfen

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Nature communications, 2022-08, Vol.13 (1), p.4931-4931, Article 4931

2022

Link zum Volltext

Verfügbarkeit prüfen

Novel assays to investigate the mechanisms of latent infection with HIV-2

PloS one, 2022-04, Vol.17 (4), p.e0267402-e0267402

2022

Link zum Volltext

Verfügbarkeit prüfen

Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial

The Lancet infectious diseases, 2014-11, Vol.14 (11), p.1055-1064

2014

Link zum Volltext

Verfügbarkeit prüfen

HIV Testing in a High-Incidence Population: Is Antibody Testing Alone Good Enough?

Clinical infectious diseases, 2009-08, Vol.49 (3), p.444-453

2009

Link zum Volltext

Verfügbarkeit prüfen

Estimating Volume of Cervicovaginal Secretions in Cervicovaginal Lavage Fluid Collected for Measurement of Genital HIV-1 RNA Levels in Women

Journal of Clinical Microbiology, 2011-02, Vol.49 (2), p.735-736

2011

Link zum Volltext

Verfügbarkeit prüfen

Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk

PloS one, 2010-09, Vol.5 (9), p.e12598-e12598

2010

Link zum Volltext

Verfügbarkeit prüfen

Herpes Simplex Virus (HSV) Suppression with Valacyclovir Reduces Rectal and Blood Plasma HIV-1 Levels in HIV-1/HSV-2-Seropositive Men: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial

The Journal of infectious diseases, 2007-11, Vol.196 (10), p.1500-1508

2007

Link zum Volltext

Verfügbarkeit prüfen

Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Nature communications, 2023-01, Vol.14 (1), p.333-333, Article 333

2023

Link zum Volltext

Verfügbarkeit prüfen

Herpes Simplex Virus (HSV)-Suppressive Therapy Decreases Plasma and Genital HIV-1 Levels in HSV-2/HIV-1 Coinfected Women: A Randomized, Placebo-Controlled, Cross-Over Trial

The Journal of infectious diseases, 2008-12, Vol.198 (12), p.1804-1808

2008

Link zum Volltext

Verfügbarkeit prüfen

A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir

Cell reports. Medicine, 2021-04, Vol.2 (4), p.100243-100243, Article 100243

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

Science translational medicine, 2022-01, Vol.14 (628), p.eabl7430

2022

Link zum Volltext

Verfügbarkeit prüfen

Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation

PloS one, 2012-07, Vol.7 (7), p.e41832-e41832

2012

Link zum Volltext

Verfügbarkeit prüfen

Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya

EClinicalMedicine, 2020-01, Vol.18, p.100239-100239, Article 100239

2020

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298

Clinical infectious diseases, 2018-10, Vol.67 (9), p.1339-1346

2018

Link zum Volltext

Verfügbarkeit prüfen

Monotypic Human Immunodeficiency Virus Type 1 Genotypes across the Uterine Cervix and in Blood Suggest Proliferation of Cells with Provirus

Journal of Virology, 2009-06, Vol.83 (12), p.6020-6028

2009

Link zum Volltext

Verfügbarkeit prüfen

Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study)

The Journal of infectious diseases, 2012-07, Vol.206 (2), p.258-266

2012

Link zum Volltext

Verfügbarkeit prüfen

The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion

AIDS (London), 2017-09, Vol.31 (14), p.2007-2016

2017

Link zum Volltext

Verfügbarkeit prüfen

Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance

Journal of clinical virology, 2020-08, Vol.129, p.104474-104474, Article 104474

2020

Link zum Volltext

Verfügbarkeit prüfen

HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy

Journal of acquired immune deficiency syndromes (1999), 2016-08, Vol.72 (5), p.579

2016

Link zum Volltext

Verfügbarkeit prüfen

Exploring the anatomical HIV reservoirs: role of the testicular tissue

AIDS (London), 2016-11, Vol.30 (18), p.2891-2893

2016

Link zum Volltext

Verfügbarkeit prüfen

Viral Load Dynamics in Plasma and Semen When Antiretroviral Therapy Is Initiated During Early HIV-1 Infection

The Journal of infectious diseases, 2023-11

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 381

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(356)
Mit Volltextzugriff
(304)

Publikationsform

Sprache

Englisch
(381)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Novel assays to investigate the mechanisms of latent infection with HIV-2

Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial

HIV Testing in a High-Incidence Population: Is Antibody Testing Alone Good Enough?

Estimating Volume of Cervicovaginal Secretions in Cervicovaginal Lavage Fluid Collected for Measurement of Genital HIV-1 RNA Levels in Women

Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk

Herpes Simplex Virus (HSV) Suppression with Valacyclovir Reduces Rectal and Blood Plasma HIV-1 Levels in HIV-1/HSV-2-Seropositive Men: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial

Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Herpes Simplex Virus (HSV)-Suppressive Therapy Decreases Plasma and Genital HIV-1 Levels in HSV-2/HIV-1 Coinfected Women: A Randomized, Placebo-Controlled, Cross-Over Trial

Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention

A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation

Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya

A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298

Monotypic Human Immunodeficiency Virus Type 1 Genotypes across the Uterine Cervix and in Blood Suggest Proliferation of Cells with Provirus

Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study)

The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion

Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance

HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy

Exploring the anatomical HIV reservoirs: role of the testicular tissue

Viral Load Dynamics in Plasma and Semen When Antiretroviral Therapy Is Initiated During Early HIV-1 Infection

Suchergebnisse filtern